https://www.insideprecisionmedicine.com/topics/oncology/targeted-therapy-helps-high-risk-pediatric-hodgkins-lymphoma/
0
0
11/3/22 at 2:52pm
Organization
Insideprecisionmedicine.com
Author
Malorye Branca
30 words
0
Comments
The targeted therapy brentuximab vedotin has significantly reduced relapse rates among children with high-risk Hodgkin's lymphoma.
You are the first to view
Create an account
or login to join the discussion